During the past decade, Hopital Saint Antoine; Hepatologie-Gastr-Enterologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Saint Antoine; Hepatologie-Gastr-Enterologie" are "Gastric Cancer" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Hopital Saint Antoine; Hepatologie-Gastr-Enterologie" in a lesser frequency.

Most popular intervention types in "Hopital Saint Antoine; Hepatologie-Gastr-Enterologie" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Taxane" (1 trials) and "trastuzumab emtansine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint Antoine; Hepatologie-Gastr-Enterologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Saint Antoine; Hepatologie-Gastr-Enterologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Saint Antoine; Hepatologie-Gastr-Enterologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint Antoine; Hepatologie-Gastr-Enterologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".